Princess Margaret Cancer Foundation
Toronto, ON M5G 2M9
President & CEO: Michael Burns
Board Chair: Glenn Ives
Charitable Reg. #: 88900 7597 RR0001
Grade: B+The grade is based on the charity's public reporting of the work it does and the results it achieves.
Need for Funding
Cents to the Cause
Full-time staff #77
Avg. Compensation $135,393
Top 10 Staff Salary Range
|$300k - $350k||2|
|$250k - $300k||3|
|$200k - $250k||3|
|$160k - $200k||0|
|$120k - $160k||0|
|$80k - $120k||0|
|$40k - $80k||0|
About Princess Margaret Cancer Foundation:
Founded in 1982, Princess Margaret Cancer Foundation (PMCF) raises money to fund research, building upgrades, and equipment purchases at Princess Margaret Cancer Centre. It is estimated that almost 50% of Canadians will develop cancer in their lifetime and 25% will die from the illness. The centre aims to “conquer cancer in our lifetime”.
In F2018, PMCF distributed $108.5 million to the cancer centre: 90% to research, education, and patient care; 8% to buildings; and 2% to equipment. The centre is visited over 400,000 times each year, including 17,797 new patients in F2017 who accessing 26 specialty clinics and 202 inpatient beds.
In F2017, the hospital employed 850 researchers and research staff. Researchers investigate the causes and treatment of cancers including using stem cells or a patient’s immune system to fight the illness.
The foundation will be renovating the main cancer clinical area. The new spaces will renovate the gynecologic cancer clinic, a new outpatient palliative care clinic, and reorganize the out-patient area. The renovated main floor will have a larger patient library for patient education, enhanced patient lounges, and new space for the foundation's fundraising.
Results and Impact:
Princess Margaret self-identifies as one of the top five cancer research centres in the world. Between 2015-2017 it ranks itself 2nd, with 15% of its research papers published in high-impact oncology journals, and ranks itself 5th with 34% of the research papers placing in the Top 10 of papers published in the same field and the same year. This compares with 15% of its research papers published in high-impact oncology journals and 34% of its research papers highly cited between 2012-2015.
In F2018, Dr. John Dick's innovative research into blood and stem cells continues. With international colleagues, Dick's research into rare acute myeloid leukemia identified trackers that will enable earlier detection and could reduce the mortality rate from its current 90% in people over 65. F2015, Princess Margaret Cancer Foundation committed $10.5 million to support the research of a team of 15 scientists. Since that time, the research team has developed two drugs to slow the spread of cancer, both of which are currently in a trial period.
Princess Margaret Cancer Foundation is a Major 100 charity, with donations and special events revenue of $98.6m in F2018. The foundation received $29.7m in net revenue from lotteries, representing 19% of total revenues. Administrative and fundraising costs are 22% of revenues, meaning that for every $1 donated, 78 cents go to the cause. This falls well within Ci’s reasonable range for overhead spending. The foundation has $631.0m in funding reserved of which $156.3m is donor-endowed. Excluding donor-endowed funds, the foundation could cover 4.7 years of granting at the F2018 level.
This charity report is an update that has been sent to Princess Margaret Cancer Foundation for review. Changes and edits may be forthcoming.
Updated on August 9, 2018 by Madison Kerr.
Financial RatiosFiscal year ending March
|Fundraising & admin costs as % of revenues||22.4%||21.4%||22.8%|
|Program cost coverage (%)||581.3%||633.6%||594.4%|
Summary Financial StatementsAll figures in $000s
|Fundraising & administrative costs||28,704||26,277||27,517|
|Cash flow from operations||22,635||45,921||(2,637)|